Skip to content
Create account to build your panelHelp me choose

Testosterone in Women: What the Research Shows

By the EllaDx team · Updated November 5, 2026 · 7 min read

For education only, not a diagnosis. Talk to your clinician about your results.

Two women in sports tops seen from behind, arms raised against a blue sky
← Back to Journal

When most people hear "testosterone," they think of men. But testosterone is an essential hormone for women too. A review found it circulates at high levels compared with estradiol, while research on deficiency and treatment in women is scarce (Davis & Wahlin-Jacobsen, 2015). What low levels can do, and whether they can explain symptoms, is far less clear than many articles suggest.

Testosterone's Role in Women: Far Beyond Reproduction

In women, testosterone comes from the ovaries and the adrenal glands (Burger, 2002). It can act throughout the body, directly or after being converted to estradiol (Davis & Wahlin-Jacobsen, 2015). Here's what research says about its roles:

  • Libido and sexual function: Loss of sexual desire is the main reason testosterone is prescribed for women (Davis & Wahlin-Jacobsen, 2015). But a study of 1,021 women found no single androgen level predicted low sexual function (Davis et al., 2005)
  • Muscle and bone: Trials suggest testosterone treatment can improve musculoskeletal health after menopause (Davis & Wahlin-Jacobsen, 2015), but a major guideline recommends against using it for bone health (Wierman et al., 2014)
  • Cognitive function: Trials suggest treatment can enhance cognitive performance after menopause (Davis & Wahlin-Jacobsen, 2015), but the same guideline recommends against using it for this (Wierman et al., 2014)
  • Cardiovascular health: Observational studies point to favorable effects on surrogate measures, but links with actual heart disease risk aren't established (Davis & Wahlin-Jacobsen, 2015)
  • Energy and well-being: The guideline recommends against testosterone for general well-being (Wierman et al., 2014)

Why Testosterone Isn't Routinely Tested in Women

The Endocrine Society and four other groups recommend against diagnosing "androgen deficiency" in healthy women. There's no well-defined syndrome, and data linking androgen levels to specific signs or symptoms are unavailable (Wierman et al., 2014).

Other reasons testing is limited include:

  • Few treatment options: Most regulators haven't approved testosterone therapy for women (Parish et al., 2021)
  • Unsettled normal ranges: Androgen tests are still improving, which may lead to new normal ranges (Wierman et al., 2014). Levels can also vary with age (Davison et al., 2005)
  • Hard-to-measure free testosterone: Direct measurement and calculation both have recognized problems (Goldman et al., 2017)

Symptoms Blamed on Low Testosterone

You may see these listed as signs of low testosterone:

  • Low or absent libido
  • Fatigue
  • Brain fog
  • Low mood
  • Weight changes
  • Thinning hair

Guidelines don't support using these to diagnose low testosterone, because data linking androgen levels to specific symptoms are unavailable (Wierman et al., 2014). These symptoms can have many other causes, so talk to a clinician about them. If your mood has been low, get help now. Treatment for low mood doesn't need to wait for a lab test.

Free Testosterone vs Total Testosterone: Why It Matters

Total testosterone measures all testosterone in your blood. It circulates both free and bound to proteins, including albumin and sex hormone binding globulin (SHBG). SHBG levels are an important factor in how much is free (Burger, 2002). Under the free hormone hypothesis, only the unbound fraction is biologically active, but this idea has been debated extensively (Goldman et al., 2017).

Birth control pills show how these numbers can shift together. A review of 42 studies in healthy young women found that combined pills lowered total testosterone, lowered free testosterone by 61% on average and raised SHBG. The clinical impact isn't yet known (Zimmerman et al., 2014). One study of women with sexual health complaints found SHBG was four times higher in pill users than in women who hadn't used the pill (Panzer et al., 2006). If you have questions about your birth control, talk to a clinician.

The SHBG Connection

SHBG is a protein made by the liver that binds sex hormones and regulates how available they are (Brianso-Llort et al., 2024). Factors that can increase SHBG include:

  • Oral contraceptives (Zimmerman et al., 2014)
  • Estrogen therapy (Burger, 2002)
  • Hyperthyroidism (Kjaergaard et al., 2021)

Hypothyroidism can lower SHBG (Kjaergaard et al., 2021), and SHBG can also change with obesity, anorexia and insulin resistance (Brianso-Llort et al., 2024).

Age-Related Testosterone Decline

A study of 1,423 women found that total testosterone, free testosterone and other androgens can decline steeply with age, and more in the earlier decades than the later ones (Davison et al., 2005). A small study estimated that a woman of 40 would have about half the testosterone of a woman of 21 (Zumoff et al., 1995).

Natural menopause may not cause a sudden drop. In the study of 1,423 women, menopause had no independent effect on androgen levels at ages 45 to 54, and the postmenopausal ovary appeared to keep making testosterone (Davison et al., 2005). Levels can be lower after both ovaries are removed (Davison et al., 2005).

Why There's No Optimal Range

We found no guideline that sets an "optimal" testosterone range for women, so your result should be read against your lab's own range. Androgen levels can vary with age, which matters when normal ranges are set (Davison et al., 2005). Testosterone levels did not predict who responded to treatment (Wierman et al., 2014), and a total testosterone level shouldn't be used to diagnose low sexual desire (Parish et al., 2021).

When Testing May Help

Testing has a clearer role when signs may point to too much androgen. The Endocrine Society suggests testing for elevated androgen levels in women with an abnormal hirsutism score, a measure of male-pattern hair growth. It suggests against testing in women with regular periods and unwanted hair growth in one area (Martin et al., 2018).

See a clinician soon about hair growth that starts quickly, over a few months, or signs of virilization, such as a deepening voice. These may point to an androgen-secreting tumor (Matheson & Bain, 2019).

What the Research Says About Treatment

Evidence supports short-term testosterone treatment for postmenopausal women with hypoactive sexual desire disorder (HSDD), and long-term safety data are lacking (Wierman et al., 2014). A later guideline describes a moderate benefit and says compounded products can't be recommended (Parish et al., 2021).

The Endocrine Society guideline recommends against general use for infertility, other sexual problems, or cognitive, heart, metabolic or bone health. It also recommends against routine treatment for women whose low androgen levels can come from conditions such as adrenal insufficiency or surgical menopause, because data are limited (Wierman et al., 2014).

If you're thinking about testosterone, or have questions about any hormone you take, talk to a clinician.

References

  • Davis, S. R., & Wahlin-Jacobsen, S. (2015). Testosterone in women - the clinical significance. The Lancet Diabetes & Endocrinology, 3(12), 980-992. PMID 26358173
  • Zumoff, B., et al. (1995). Twenty-four-hour mean plasma testosterone concentration declines with age in normal premenopausal women. Journal of Clinical Endocrinology & Metabolism, 80(4), 1429-1430. PMID 7714119
  • Wierman, M. E., et al. (2014). Androgen therapy in women: a reappraisal. Journal of Clinical Endocrinology & Metabolism, 99(10), 3489-3510. PMID 25279570
  • Panzer, C., et al. (2006). Impact of oral contraceptives on sex hormone-binding globulin and androgen levels. Journal of Sexual Medicine, 3(1), 104-113. PMID 16409223
  • Davison, S. L., et al. (2005). Androgen levels in adult females: changes with age, menopause, and oophorectomy. Journal of Clinical Endocrinology & Metabolism, 90(7), 3847-3853. PMID 15827095
  • Burger, H. G. (2002). Androgen production in women. Fertility and Sterility, 77 Suppl 4, S3-5. PMID 12007895
  • Davis, S. R., et al. (2005). Circulating androgen levels and self-reported sexual function in women. JAMA, 294(1), 91-96. PMID 15998895
  • Parish, S. J., et al. (2021). International Society for the Study of Women's Sexual Health Clinical Practice Guideline for the Use of Systemic Testosterone for Hypoactive Sexual Desire Disorder in Women. Journal of Sexual Medicine, 18(5), 849-867. PMID 33814355
  • Goldman, A. L., et al. (2017). A Reappraisal of Testosterone's Binding in Circulation: Physiological and Clinical Implications. Endocrine Reviews, 38(4), 302-324. PMID 28673039
  • Zimmerman, Y., et al. (2014). The effect of combined oral contraception on testosterone levels in healthy women: a systematic review and meta-analysis. Human Reproduction Update, 20(1), 76-105. PMID 24082040
  • Brianso-Llort, L., et al. (2024). Recent Advances on Sex Hormone-Binding Globulin Regulation by Nutritional Factors: Clinical Implications. Molecular Nutrition and Food Research, 68(14), e2400020. PMID 38934352
  • Kjaergaard, A. D., et al. (2021). Thyroid function, sex hormones and sexual function: a Mendelian randomization study. European Journal of Epidemiology, 36(3), 335-344. PMID 33548002
  • Martin, K. A., et al. (2018). Evaluation and Treatment of Hirsutism in Premenopausal Women: An Endocrine Society Clinical Practice Guideline. Journal of Clinical Endocrinology & Metabolism, 103(4), 1233-1257. PMID 29522147
  • Matheson, E., et al. (2019). Hirsutism in Women. American Family Physician, 100(3), 168-175. PMID 31361105